ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,951.20
      0.53%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.225
      -0.22%
      Bitcoin
      56,990.90
      0.50%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axonics Inc (AXNX)

      7. Axonics Inc (AXNX) News

      AXNX

      Axonics (AXNX)

      Axonics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXNX
      DateTimeSourceHeadlineSymbolCompany
      04/06/20234:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXNXAxonics Inc
      03/29/20236:00AMBusiness WireAxonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the AmericasNASDAQ:AXNXAxonics Inc
      03/10/20238:00AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AXNXAxonics Inc
      03/07/20236:00AMBusiness WireAxonics to Participate in the SUFU 2023 Winter MeetingNASDAQ:AXNXAxonics Inc
      03/01/20234:01PMBusiness WireAxonics Reports Fourth Quarter and Fiscal Year 2022 Financial ResultsNASDAQ:AXNXAxonics Inc
      02/08/20234:30PMBusiness WireAxonics to Report Fourth Quarter 2022 Financial Results on March 1NASDAQ:AXNXAxonics Inc
      01/31/20232:00PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AXNXAxonics Inc
      01/31/20236:00AMBusiness WireAxonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
      01/11/20234:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXNXAxonics Inc
      01/11/20236:00AMBusiness WireAxonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue GuidanceNASDAQ:AXNXAxonics Inc
      12/21/20226:00AMBusiness WireAxonics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:AXNXAxonics Inc
      12/13/20226:00AMBusiness WireAxonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
      11/18/20226:00AMBusiness WireAxonics® to Participate in the Piper Sandler Healthcare ConferenceNASDAQ:AXNXAxonics Inc
      11/16/202211:06AMBusiness WireAxonics® Ranked No. 4 on the 2022 Deloitte Technology Fast 500™ List of the Fastest Growing Companies in North AmericaNASDAQ:AXNXAxonics Inc
      11/09/20224:11PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AXNXAxonics Inc
      11/01/20225:45AMTipRanksNeedham Remains a Hold on Axonics Modulation Technologies (AXNX)NASDAQ:AXNXAxonics Inc
      10/31/20224:01PMBusiness WireAxonics® Reports Third Quarter 2022 Financial ResultsNASDAQ:AXNXAxonics Inc
      09/08/20226:00AMBusiness WireAxonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
      08/18/20226:00AMBusiness WireAxonics® to Participate in September Investor ConferencesNASDAQ:AXNXAxonics Inc
      08/17/20226:00AMBusiness WireAxonics® Expands Sacral Neuromodulation Intellectual Property PortfolioNASDAQ:AXNXAxonics Inc
      08/12/20227:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXNXAxonics Inc
      08/12/20227:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXNXAxonics Inc
      08/10/20227:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXNXAxonics Inc
      08/05/20224:43PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXNXAxonics Inc
      08/05/20224:34PMBusiness WireAxonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional StockNASDAQ:AXNXAxonics Inc
      08/02/202211:13PMBusiness WireAxonics® Announces Pricing of Public Offering of Common StockNASDAQ:AXNXAxonics Inc
      08/02/20225:28PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AXNXAxonics Inc
      08/02/20224:38PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AXNXAxonics Inc
      08/02/20224:11PMBusiness WireAxonics® Announces Proposed Public Offering of Common StockNASDAQ:AXNXAxonics Inc
      08/02/20226:06AMTipRanksAxonics Modulation Technologies (AXNX) Received its Third Buy in a RowNASDAQ:AXNXAxonics Inc
       Showing the most relevant articles for your search:NASDAQ:AXNX